(Q33364407)

26 July 2017

De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases (English)

1 reference

26 July 2017

1 reference

R John Crew

1

1 reference

26 July 2017

Jai Radhakrishnan

2

1 reference

26 July 2017

David J Cohen

3

1 reference

26 July 2017

Leonard Stern

4

1 reference

26 July 2017

Michael Goldstein

5

1 reference

26 July 2017

Mark Hardy

6

1 reference

26 July 2017

Vivette D D'Agati

7

1 reference

26 July 2017

Glen S Markowitz

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Nephrology Dialysis Transplantation

26 July 2017

1 reference

26 July 2017

20

1 reference

26 July 2017

1

1 reference

26 July 2017

203-209

1 reference

De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy

26 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Thrombotic microangiopathy after renal transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

TOR, a central controller of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Sirolimus may promote thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Sirolimus-induced thrombotic microangiopathy in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Renal vascular and thrombotic effects of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Flow-induced DNA synthesis requires signaling to a translational control pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Enhancement of human platelet aggregation and secretion induced by rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

Sirolimus-based immunosuppression for transplant-associated thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

De novo hemolytic-uremic syndrome/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: role of sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH334

21 January 2018

Identifiers

DOI

10.1093/NDT/GFH334

1 reference

26 July 2017

1 reference